Polymer zwitterion-temozolomide conjugates for glioblastoma treatment

被引：0
|
作者：
Ward, Sarah [1 ]
Skinner, Matthew [1 ]
Saha, Banishree [1 ]
Emrick, Todd [1 ]
机构：
[1] Univ Massachusetts, Polymer Sci & Engn, Amherst, MA 01003 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
57
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Radiotherapy with concomitant and sequential temozolomide compared with radiotherapy with sequential temozolomide in the treatment of glioblastoma multiforme
    De Sanctis, V
    Osti, MF
    Donato, V
    Valeriani, M
    Salvati, M
    Del Bufalo, S
    Mazzarella, G
    Minniti, G
    Tombolini, V
    Enrici, RM
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S259 - S259
  • [42] A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma
    Kong, Doo-Sik
    Lee, Jung-Il
    Kim, Won Seog
    Son, Myung Jin
    Lim, Do Hoon
    Kim, Sung Tae
    Park, Kwan
    Kim, Jong Hyun
    Eoh, Whan
    Nam, Do-Hyun
    ONCOLOGY REPORTS, 2006, 16 (05) : 1117 - 1121
  • [43] Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
    Zhao, Mingming
    Ma, Haodong
    Cheng, Peng
    Yang, Hongjie
    Zhao, Yang
    Han, Qian
    MEDICINE, 2022, 101 (49) : E32156
  • [44] Benefit of a prolonged adjuvant treatment with temozolomide for the management of patients with glioblastoma
    Malkoun, N.
    Fotso, M. -J.
    Cartier, L.
    Forest, F.
    Auberdiac, P.
    Chargari, C.
    Thorin, J.
    Pacaut, C.
    Peoc'h, M.
    Nuti, C.
    Schmitt, T.
    Magne, N.
    CANCER RADIOTHERAPIE, 2011, 15 (03): : 202 - 207
  • [45] TREATMENT OF RECURRENT GLIOBLASTOMA WITH THE CYTOKINE INHIBITOR, IBUDILAST IN COMBINATION WITH TEMOZOLOMIDE
    McDonald, K. L.
    Ha, W.
    Khasraw, M.
    NEURO-ONCOLOGY, 2017, 19 : 27 - 27
  • [46] Treatment outcome of temozolomide in elderly patients with glioblastoma: A systematic review
    Sebastian, A.
    Darmajaya, G. J.
    Law, N. K.
    Sutanto, M.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S520 - S520
  • [47] Survival Benefit of Temozolomide as Treatment for Glioblastoma; a Population Based Analysis
    Wachtel, M. S.
    Miller, B. B.
    LABORATORY INVESTIGATION, 2012, 92 : 437A - 437A
  • [48] Survival Benefit of Temozolomide as Treatment for Glioblastoma; a Population Based Analysis
    Wachtel, M. S.
    Miller, B. B.
    MODERN PATHOLOGY, 2012, 25 : 437A - 437A
  • [49] Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide
    Stuplich, Moritz
    Hadizadeh, Dariusch R.
    Kuchelmeister, Klaus
    Scorzin, Jasmin
    Filss, Christian
    Langen, Karl-Josef
    Schaefer, Niklas
    Mack, Frederic
    Schueller, Heinrich
    Simon, Matthias
    Glas, Martin
    Pietsch, Torsten
    Urbach, Horst
    Herrlinger, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : E180 - E183
  • [50] Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme
    Oh, J.
    Kutas, G. J.
    Davey, P.
    Morrison, M.
    Perry, J. R.
    CURRENT ONCOLOGY, 2010, 17 (04) : 124 - 126
12345